Bright Minds Biosciences Announces Listing on Canadian Stock Exchange Feb 8 • 2 min read Bright Minds Biosciences today announced that the company’s common shares are expected to commence trading on the Canadian Securities Exchange on Monday, February 8, 2021, under the ticker symbol “DRUG.”
Mindset Files Multiple Final Patent Applications on Its Novel Psilocybin-Inspired Compounds Feb 5 • 3 min read Mindset Pharma Inc. announced that the company has filed 3 final patent applications with the U.S. Patent and Trademark Office.
Dr. Robin Carhart-Harris joins Osmind as a Scientific Advisor Feb 4 • 3 min read Osmind is adding Dr. Robin Carhart-Harris as a Scientific Advisor.
Champignon Brands : New Rapid mood Screener (RMS) Screens for Manic Symptoms and Bipolar I Disorder Features to Address Unmet Clinical Need Feb 3 • 4 min read Champignon Brands Inc. announces the publication of an article led by Dr. Roger McIntyre, CEO of Champignon Brands Inc.
MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics Feb 2 • 4 min read MindMed streamlined its leadership team to further develop the company’s strategy of integrating its psychedelic clinical development programs with innovative digital technologies.